{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:06:27Z","timestamp":1789653987911,"version":"4.0.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Inserm Cancer","award":["(REMOTE, 20CN063)"],"award-info":[{"award-number":["(REMOTE, 20CN063)"]}]},{"name":"Inserm Cancer","award":["(REMOTE, 20CN063)"],"award-info":[{"award-number":["(REMOTE, 20CN063)"]}]},{"name":"LabEx DEVweCan","award":["(ANR-10-LABX-0061)"],"award-info":[{"award-number":["(ANR-10-LABX-0061)"]}]},{"name":"LabEx DEVweCan","award":["(ANR-10-LABX-0061)"],"award-info":[{"award-number":["(ANR-10-LABX-0061)"]}]},{"name":"Institut Convergence Plascan","award":["(ANR-17-CONV-0002)"],"award-info":[{"award-number":["(ANR-17-CONV-0002)"]}]},{"name":"LYriCAN+","award":["(INCa-DGOS-INSERM-ITMO cancer_18003)"],"award-info":[{"award-number":["(INCa-DGOS-INSERM-ITMO cancer_18003)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-026-00247-5","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:52:22Z","timestamp":1789653142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-662 impairs C\/D box snoRNA expression and rRNA 2\u2032-O-ribose methylation marks"],"prefix":"10.1038","volume":"4","author":[{"given":"Charlotte","family":"Filossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cl\u00e9zardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moyret-Lalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Marcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Puppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"247_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41416-023-02340-9","volume":"129","author":"M Puppo","year":"2023","unstructured":"Puppo M, Valluru MK, Croset M, Ceresa D, Iuliani M, Khan A, et al. MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness. Br J Cancer. 2023;129:754\u201371. https:\/\/doi.org\/10.1038\/s41416-023-02340-9.","journal-title":"Br J Cancer"},{"key":"247_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01934-2","volume":"26","author":"M Puppo","year":"2024","unstructured":"Puppo M, Croset M, Ceresa D, Valluru MK, Canuas Landero VG, Hernandez Guadarrama M, et al. Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. Breast Cancer Res. 2024;26:186. https:\/\/doi.org\/10.1186\/s13058-024-01934-2.","journal-title":"Breast Cancer Res"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","volume":"21","author":"L Fabbri","year":"2021","unstructured":"Fabbri L, Chakraborty A, Robert C, Vagner S. The plasticity of mRNA translation during cancer progression and therapy resistance. Nat Rev Cancer. 2021;21:558\u201377. https:\/\/doi.org\/10.1038\/s41568-021-00380-y.","journal-title":"Nat Rev Cancer"},{"key":"247_CR4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2408114121","volume":"121","author":"C Morin","year":"2024","unstructured":"Morin C, Baudin-Baillieu A, Van Long FN, Isaac C, Bidou L, Arbes H, et al. Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition. Proc Natl Acad Sci USA. 2024;121:e2408114121. https:\/\/doi.org\/10.1073\/pnas.2408114121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cells10081948","volume":"10","author":"M Jaafar","year":"2021","unstructured":"Jaafar M, Paraqindes H, Gabut M, Diaz JJ, Marcel V, Durand S. 2\u2019O-Ribose methylation of ribosomal RNAs: natural diversity in living organisms, biological processes, and diseases. Cells. 2021;10:1948 https:\/\/doi.org\/10.3390\/cells10081948.","journal-title":"Cells"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"e983755","DOI":"10.4161\/23723556.2014.983755","volume":"2","author":"V Marcel","year":"2015","unstructured":"Marcel V, Catez F, Diaz JJ. Ribosome heterogeneity in tumorigenesis: the rRNA point of view. Mol Cell Oncol. 2015;2:e983755 https:\/\/doi.org\/10.4161\/23723556.2014.983755.","journal-title":"Mol Cell Oncol"},{"key":"247_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/cancers15010242","volume":"15","author":"M Puppo","year":"2022","unstructured":"Puppo M, Jaafar M, Diaz JJ, Marcel V, Cl\u00e9zardin P. MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential. Cancers. 2022;15:242 https:\/\/doi.org\/10.3390\/cancers15010242.","journal-title":"Cancers"},{"key":"247_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09552-x","volume":"22","author":"F Nguyen Van Long","year":"2022","unstructured":"Nguyen Van Long F, Lardy-Cleaud A, Car\u00e8ne D, Rossoni C, Catez F, Rollet P, et al. Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer. BMC Cancer. 2022;22:526. https:\/\/doi.org\/10.1186\/s12885-022-09552-x.","journal-title":"BMC Cancer"},{"key":"247_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-1-4939-6807-7_12","volume":"1562","author":"V Marchand","year":"2017","unstructured":"Marchand V, Ayadi L, El Hajj A, Blanloeil-Oillo F, Helm M, Motorin Y. High-throughput mapping of 2\u2032-O-me residues in RNA using next-generation sequencing (Illumina ribomethseq protocol). Methods Mol Biol. 2017;1562:171\u201387.","journal-title":"Methods Mol Biol"},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/neuonc\/noad140","volume":"25","author":"H Paraqindes","year":"2023","unstructured":"Paraqindes H, Mourksi NE, Ballesta S, Hedjam J, Bourdelais F, Fenouil T, et al. Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2\u2019O-methylation of ribosomal RNA. Neuro Oncol. 2023;25:2191\u2013206. https:\/\/doi.org\/10.1093\/neuonc\/noad140.","journal-title":"Neuro Oncol"},{"key":"247_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcaa036","volume":"2","author":"V Marcel","year":"2020","unstructured":"Marcel V, Kielbassa J, Marchand V, Natchiar KS, Paraqindes H, Nguyen Van Long F, et al. Ribosomal RNA 2\u2019O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer. NAR Cancer. 2020;2:zcaa036. https:\/\/doi.org\/10.1093\/narcan\/zcaa036.","journal-title":"NAR Cancer"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/nar\/gkad1235","volume":"52","author":"CJ Bryant","year":"2024","unstructured":"Bryant CJ, McCool MA, Rosado Gonz\u00e1lez GT, Abriola L, Surovtseva YV, Baserga SJ. Discovery of novel microRNA mimic repressors of ribosome biogenesis. Nucleic Acids Res. 2024;52:1988\u20132011. https:\/\/doi.org\/10.1093\/nar\/gkad1235.","journal-title":"Nucleic Acids Res"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00247-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:52:23Z","timestamp":1789653143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1038\/s44276-026-00247-5","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"47"}}